Skip to main content

Table 3 Adverse events by age, weight range, and treatment arm

From: Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial

  Treatment group
n (%)
ASMQ + Pq CQ + Pq AL + Pq
Age (years)
 > 59 14 (30.4) 21 (45.7) 11 (23.9)
 18–39 190 (25.4) 255 (34.0) 304 (40.6)
 39–59 199 (24.9) 367 (46.0) 232 (29.1)
Weight (kg)
 50–70 131 (20.2) 238 (36.8) 278 (43.0)
 70–80 118 (25.8) 214 (46.7) 126 (27.5)
 80–90 154 (31.6) 191 (39.1) 143 (29.3)